Tahara K, Yamamoto K, Tamura Y, Yoshida S
Second Department of Internal Medicine, Chiba University School of Medicine.
Nihon Rinsho. 1994 Apr;52(4):1031-6.
Graves' disease and idiopathic myxedema are autoimmune thyroid diseases and are caused by thyrotropin (TSH) receptor autoantibodies, thyroid stimulating antibody (TSAb) in Graves' disease and thyroid stimulation blocking antibody (TSBAb) in idiopathic myxedema. Studies with TSH receptor/lutropin-chorionic gonadotropin (LH-CG) receptor chimeras show that binding sites or epitopes on human TSH receptor for TSH, TSAb and TSBAb are different and, moreover, epitopes for TSAb are heterogeneous in different Graves' patients. Epitopes for TSAb exist in the N-terminal region and those for TSBAb in the C-terminal region on human TSH receptor extracellular domain.
格雷夫斯病和特发性黏液水肿是自身免疫性甲状腺疾病,由促甲状腺激素(TSH)受体自身抗体引起,格雷夫斯病中的甲状腺刺激抗体(TSAb)和特发性黏液水肿中的甲状腺刺激阻断抗体(TSBAb)。对TSH受体/促黄体生成素 - 绒毛膜促性腺激素(LH - CG)受体嵌合体的研究表明,人TSH受体上TSH、TSAb和TSBAb的结合位点或表位不同,此外,不同格雷夫斯病患者中TSAb的表位是异质性的。TSAb的表位存在于人TSH受体胞外域的N端区域,TSBAb的表位存在于C端区域。